{
  "docId": "019dd923-622c-750b-8b9a-1a3bea94baf9",
  "docSlug": "c358888161f0",
  "documentTitle": "Ginkgo Bioworks (DNA)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-10-06 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.2941177,
  "pageNumber": 148,
  "pageCount": 175,
  "prevPage": 147,
  "nextPage": 149,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "The slide uses a Q&A format to present expert testimony.",
  "elementsJson": [
    "paragraph",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-1a3bea94baf9/148",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-1a3bea94baf9",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-1a3bea94baf9.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-1a3bea94baf9#slide-148",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "I would say not, mostly because of what I was talking about before. I think Ginkgo is overvalued. I can't understand the basis for the hype.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-2b62-723f-b691-7d7de3509307",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.65
      },
      "kind": "paragraph",
      "text": "Joyn Bio can't point to anything different at Ginkgo's foundry vs. other strain engineering service providers",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "652566a7-ec4b-45cf-b754-43543ae70cd3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "Joyn executive wouldn't invest in Ginkgo; can't understand the “hype”; not differentiated and syntenic biology is becoming a commodity",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "df759fb9-2568-43b0-9eec-f424f610a875",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.9,
        "x": 0.05,
        "y": 0.28
      },
      "kind": "quote",
      "text": "Q: “Would you ever personally invest in Ginkgo?” A: “I would say not... I can't understand the basis for the hype... you have to be differentiated... synthetic biology, as people talk about it industrially, are a little bit that they are ripe to be commoditized.”",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1707ec9f-6017-4384-8ea9-863fa2a320e0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.71
      },
      "kind": "quote",
      "text": "Q: “The foundry services that Ginkgo provides, are these are basically services you can get from a lot of other people?” A: “Yeah, I would say there's probably—it would be hard for me to point to something that they do that is totally different than anybody else in the industry.”",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "54156127-76f6-4dc3-80a7-9d4db1beae19",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“I would say not, mostly because of what I was talking about before. I think Ginkgo is overvalued. I can't understand the basis for the hype...Like I said before, you have to be able to—I think you have to be differentiated in some way to be competing against...Let's take a step back. Think about DNA sequencing. There was a point where that was something special, and people would do it in-house.. And now it's become effectively commoditized. So, what's differentiating about DNA sequencing? Maybe you have enormous capacity, or maybe you have super, super-fast turnaround, or maybe you're the backend, but it's hard to be special as a sequencing company. And I worry that some of the other elements of synthetic biology, as people talk about it industrially, are a little bit that they are ripe to be commoditized. What I don't have a vision of for Ginkgo is what is it about them that's going to be in that context is going to be differentiating?” — Current Joyn executive",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-2b62-723f-b691-810fd9c04713",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.05,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9848f3f3-6edb-449e-82a1-27c19015b5a9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "A current executive at key related-party “customer” Joyn Bio – co-located in Ginkgo’s Boston offices and foundry – corroborated comments by ex-employees that Ginkgo’s foundry services are nothing differentiated",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9bd03ff9-adf2-48ac-af3a-0b03d0543e20",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "antagonist-introduction",
      "slug": null,
      "matchId": "cec3ce01-7105-40ed-98e5-97f74fa30893",
      "evidence": "Uses expert testimony to frame the company as lacking differentiation.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 175,
      "from": 9,
      "beatId": "ffe290af-3a4f-4e06-8d60-dfbfc07d2e08",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Expose Contradiction",
      "beatSlug": null,
      "evidence": "The deck presents evidence contradicting Ginkgo's claims and highlighting potential wrongdoings.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}